2-(imidazol-1-yl)-1-hydroxyethylidene-1,1-bisphosphonic acid,
CGP 42'446,
CGP 42446,
CGP 42446A,
CGP-42'446,
CGP-42446,
CGP42'446,
CGP42446,
zoledronate,
zoledronic acid,
zoledronic acid anhydrous,
Zometa,
Zoledronic acid hydrate,
Zoledronic acid monohydrate,
165800-06-6,
(1-Hydroxy-2-(1H-imidazol-1-yl)ethane-1,1-diyl)diphosphonic acid hydrate,
Zoledronic acid (monohydrate),
UNII-6XC1PAD3KF,
C5H10N2O7P2.H2O,
Zoledronate monohydrate,
MFCD08448695,
6XC1PAD3KF,
Phosphonic acid, [1-hydroxy-2-(1H-imidazol-1-yl)ethylidene]bis-, monohydrate,
Orazol,
(1-Hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid, monohydrate,
Zometa (TN),
(1-hydroxy-2-imidazol-1-yl-1-phosphono-ethyl)phosphonic acid hydrate,
Phosphonic acid, (1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bis-, monohydrate,
CGP-42446A,
CGP-42446B,
Zoledronic acid [USAN:INN:BAN],
MER-101,
zoledronicacidforinjection,
Zoledronic acid (USAN),
NPFAPI-10,
AC1L3T0M,
KSC532C6T,
SCHEMBL435847,
Zoledronic acid hydrate (JAN),
CTK4D2169,
DTXSID10168029,
ZOL-446,
FUXFIVRTGHOMSO-UHFFFAOYSA-N,
HMS3715J20,
BCP10611,
KS-00000L2O,
AK-156,
HY-13777A,
AKOS005766026,
AC-5897,
CCG-221249,
CCG-222039,
CM14379,
CS-2975,
KS-1132,
AK151131,
AN-10491,
BC653685,
H683,
AB0005369,
LS-173596,
ST2402089,
FT-0696857,
Zoledronic acid monohydrate, >=98% (HPLC),
D01968,
800P066,
A803876,
J-010227,
I14-13354,
(1-hydroxy-2-imidazol-1-yl-1-phosphonoethyl)phosphonic acid hydrate,
(1-hydroxy-2-imidazol-1-yl-1-phosphonoethyl)phosphonic acid;hydrate,
(1-hydroxy-2-imidazol-1-yl-1-phosphonoethyl)phosphonicacid,hydrate,
(1-Hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid monohydrate,
1-Hydroxy-2-(1-imidazolyl)ethane-1,1-diphosphonic acid monohydrate,
Zoledronic acid, United States Pharmacopeia (USP) Reference Standard,
(2-imidazol-1-yl-1-oxidanyl-1-phosphono-ethyl)phosphonic acid hydrate,
[1-hydroxy-(1h-imidazol-1-yl)-phosphonoethyl] phosphonic acid monohydrate,
[1-hydroxy-2-(1-imidazolyl)-1-phosphonoethyl]phosphonic acid hydrate,
[1-hydroxy-2-(1H-imidazol-1-yl)-1-phosphonoethyl]phosphonic acid hydrate,
[1-hydroxy-2-(1h-imidazol-1-yl)-ethylidene]bisphosphonic acid monohydrate,
1-hydroxy-2-(1H-imidazol-1-yl)ethane-1,1-diyldiphosphonic acid hydrate,
[1-hydroxy-2-(1H-imidazol-1-yl)ethane-1,1-diyl]bis(phosphonic acid) monohydrate,
P,P'-[1-Hydroxy-2-(1H-imidazol-1-yl)ethylidene]bisphosphonic acid monohydrate,
Phosphonic acid, P,P'-[1-hydroxy-2-(1H-imidazol-1-yl)ethylidene]bis-, hydrate (1:1),
Phosphonic acid,P,P'-[1-hydroxy-2-(1H-imidazol-1-yl)ethylidene]bis-, hydrate (1:1),
Zoledronic Acid, Pharmaceutical Secondary Standard; Certified Reference Material,
Zoledronic acid,
Zometa,
Zoledronate,
Aclasta,
Reclast,
Zoledronic acid oral,
Zoledronic acid (hydrate),
D0O0LC,
165800-06-6 (hydrate),
CGP-42446,
CID121586,
ACN-034381,
CS-O-02601,
C5-H10-N2-O7-P2.H2-O,
118072-93-8,
1715H,
Zoledronic acid monohydrate, 98%, Bone resorption inhibitor - 1G 1g,